Cis Atracurium Besylate | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cis Atracurium Besylate
Europe

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Cis Atracurium Besylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 11 USDMF, 6 CEP/COS, 1 EU WC, 5 NDC API, 17 Listed Suppliers, $ API Reference Price

25 API Suppliers
11 USDMF
6 CEP/COS
1 EU WC
5 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

88 FDF Dossiers, 45 FDA Orange Book, 2 Europe, 1 Canada, 11 South Africa, 29 Listed Dossiers

88 FDF Dossiers
45 FDA Orange Book
2 Europe
1 Canada
11 South Africa
29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 2 Finar

1 Nanjing Well Pharmaceutical
1 Actylis
2 Finar

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Topical, 1 Solubilizers

2 Parenteral
2 Topical
1 Solubilizers

DIGITAL CONTENT

26 NEWS #PharmaBuzz

26 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 Finished Drug Prices

2 Finished Drug Prices

MARKET PLACE

13 APIs, 10 FDF Dossiers

13 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 1 Others

1 EDQM
2 USP
1 Others

$ API Ref.Price (USD/KG) : 36,786 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2GlaxoSmithKline leads AS

filter Active Ingredients Reset all filters

2 All

01 2Cisatracurium

filter Dosage Form Reset all filters

2 All

01 2Injection fluid, resolution

filter Country Reset all filters

2 All

01 2Norway

filter Brand Name Reset all filters

2 All

01 2Nimbex

Synnat Cisatracurium Besylate

List of Suppliers

Product Main Page

01

GlaxoSmithKline leads AS

PharmScience R&D

Not Confirmed

GlaxoSmithKline leads AS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Norway

Cisatracurium

Brand Name : Nimbex

Dosage Form : Injection fluid, resolution

Dosage Strength : 2 mg/ml

Packaging : Ampoule of glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline leads AS

PharmScience R&D

Not Confirmed

GlaxoSmithKline leads AS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Norway

Cisatracurium

Brand Name : Nimbex

Dosage Form : Injection fluid, resolution

Dosage Strength : 2 mg/ml

Packaging : Ampoule of glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!